ALGN
US EQUITY
Health Care
Health Care Supplies
CIK: 1097149
Align Technology (ALGN) Quant Factor Diagnostic & Fair Value Model
Align Technology (Ticker: ALGN) is listed in the Health Care sector (Health Care Supplies). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$154.51
-0.64%
Latest Close (2026-10-23)
Market Cap: -
P/E Ratio: 25.6
Momentum Strength
3M / 12M
-8.06%
1M: +6.10%
12M: +13.96%
Quality (ROE)
Point-in-Time
+10.23%
Trailing Return on Equity
Technical Trend
RSI 14
75.0
SMA50: $152.07
SMA200: $169.28
Valuation Multiplier
Trailing
25.6
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
ALGN trades within a typical sector multiple band (25.6x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线整理 (MA20/50)
Piotroski F-Score: 6/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1097149 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-05 | - | $108.29M | $343.80M | $1.51 |
| 10-Q | 2025-12-31 | 2026-08-05 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-05 | - | $124.61M | $181.33M | $1.72 |
| 10-Q | 2026-03-31 | 2026-05-06 | - | $112.77M | $151.04M | $1.57 |
| 10-Q | 2025-03-31 | 2026-05-06 | - | $93.23M | $52.68M | $1.27 |
| 10-K | 2025-12-31 | 2026-02-27 | - | $410.35M | $593.22M | $5.65 |
| 10-K | 2024-12-31 | 2026-02-27 | - | $421.36M | $738.23M | $5.62 |
| 10-K | 2023-12-31 | 2026-02-27 | - | $445.05M | $785.78M | $5.81 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Align Technology (ALGN) valuation multiples, momentum factors, and point-in-time filing conventions.
How should ALGN's current valuation multiple be interpreted? ↓
ALGN trades at a trailing P/E of 25.6x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are ALGN's key momentum and technical factor indicators? ↓
As of the latest close, ALGN shows a 1-month return of +6.10%, 3-month return of -8.06%, and 12-month return of +13.96%, with a 14-day RSI of 75.0. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for ALGN? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can ALGN be incorporated into systematic factor models? ↓
ALGN can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.